John Owen Brennan

John Owen Brennan is a declared insider of ImmunityBio, Inc., with filings sourced from SEC (Form 4). The record holds 3 filings, all for trades on 2 June 2023.

No open-market sale appears; the market trades are 3 purchases worth €66k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Half of the purchases are above €26k and half below. 3 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -55.6%. This is a record of the past, not a forecast.

On 5 June 2023 came the latest disclosure, an open-market purchase for €26k in ImmunityBio, Inc. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.